Diabetes drug canagliflozin associated with amputation risk in older adults: BMJ Medha Baranwal26 Aug 2020 6:42 PM IST USA: The increased amputation risk associated with the use of the diabetes drug canagliflozin is small and most obvious in older adults having...
Empagliflozin add on to insulin premix effectively lowers blood sugar in diabetes: Study Medha Baranwal25 Aug 2020 7:09 PM ISTTaiwan: The addition of SGLT2 inhibitor empagliflozin versus linagliptin for 24 weeks to premixed insulin provides better blood sugar...
SGLT2 inhibitors may increase risk of genital mycotic infections, finds review Medha Baranwal22 Aug 2020 10:30 AM ISTUSA: Researchers have found in a review that the use of SGLT2 inhibitors increases the risk of mild genital mycotic infections (GMIs). Due to which...
No increased risk of Knee Amputations with SGLT2 Inhibitors, finds study Dr Satabdi Saha17 Aug 2020 2:26 PM ISTA recent study has reported no association between SGLT2 inhibitor use and incident below-knee amputations among patients with type 2 diabetes when...
Rosuvastatin coprescription with canagliflozin tied to Statin toxicity Hina Zahid4 Aug 2020 12:30 PM ISTResearchers have found in a case study that Coprescription of rosuvastatin and canagliflozin may lead to Statin toxicity.Physicians should be aware...
Ertugliflozin reduces hospitalization risk due to heart failure in diabetes Medha Baranwal25 Jun 2020 10:45 AM ISTDelhi: SGTL2 inhibitor ertugliflozin reduces heart failure hospitalization risk but does not confer a cardiovascular mortality benefit in...
Metformin and SGLT2 Inhibitor combo helps attain HbA1c of <8% in most Diabetics Dr.Niharika Harsha B18 Jun 2020 10:44 AM ISTComplex pathophysiology and multiple physiological factors play a key role in the onset and the progression of Diabetes Mellitus. Combination therapy...
ADA 2020: Empagliflozin reduces insulin need in diabetes patients Medha Baranwal17 Jun 2020 8:36 PM ISTDelhi: Treatment with the SGLT2 inhibitor empagliflozin reduces dependency on insulin in patients with type 2 diabetes (T2D) and cardiovascular...
SGLT2 inhibitor dapagliflozin when used for heart failure may prevent diabetes Dr. Kamal Kant Kohli16 Jun 2020 10:06 AM ISTChicago, Illinois- Analysis of large international DAPA-HF trial participants notes diabetes prevention benefit in patients with heart failure who...
Ertugliflozin protects kidneys while lowering blood sugar in diabetes Dr. Kamal Kant Kohli2 Jun 2020 12:15 PM ISTSodium-glucose cotransporter 2 (SGLT2) inhibitors are associated with protective renal and cardiovascular effects in addition to lowering blood sugar...
Dapagliflozin may reduce atrial fibrillation/flutter in diabetes patients: Circulation Medha Baranwal9 Feb 2020 11:15 AM ISTDelhi: SGLT2 inhibitor dapagliflozin reduced the incidence of reported episodes of atrial fibrillation/atrial flutter (AF/AFL) adverse events in...
